Ascendis Pharma A/S (ASND)
USD 156.67
(-0.93%)
USD 156.67
(-0.93%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 971.28 Million EUR | 17.53% |
| 2022 | 826.39 Million EUR | 310.56% |
| 2021 | 201.28 Million EUR | 42.67% |
| 2020 | 141.08 Million EUR | 77.2% |
| 2019 | 79.61 Million EUR | 104.58% |
| 2018 | 38.91 Million EUR | 63.74% |
| 2017 | 23.76 Million EUR | 76.61% |
| 2016 | 13.45 Million EUR | 17.59% |
| 2015 | 11.44 Million EUR | -11.01% |
| 2014 | 12.86 Million EUR | -36.95% |
| 2013 | 20.39 Million EUR | -14.47% |
| 2012 | 23.84 Million EUR | 5.6% |
| 2011 | 22.58 Million EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 1.08 Billion EUR | 3.72% |
| 2024 Q1 | 1.04 Billion EUR | 7.15% |
| 2023 Q3 | 946.64 Million EUR | 24.73% |
| 2023 Q4 | 971.28 Million EUR | 2.6% |
| 2023 FY | 971.28 Million EUR | 17.53% |
| 2023 Q1 | 799.07 Million EUR | -3.31% |
| 2023 Q2 | 758.98 Million EUR | -5.02% |
| 2022 FY | 826.39 Million EUR | 310.56% |
| 2022 Q4 | 826.39 Million EUR | 0.55% |
| 2022 Q3 | 821.86 Million EUR | 14.31% |
| 2022 Q2 | 718.98 Million EUR | 2.07% |
| 2022 Q1 | 704.43 Million EUR | 249.97% |
| 2021 FY | 201.28 Million EUR | 42.67% |
| 2021 Q2 | 164.36 Million EUR | 1.15% |
| 2021 Q3 | 211.67 Million EUR | 28.78% |
| 2021 Q4 | 201.28 Million EUR | -4.91% |
| 2021 Q1 | 162.49 Million EUR | 15.18% |
| 2020 Q3 | 94.53 Million EUR | 13.27% |
| 2020 Q4 | 141.08 Million EUR | 49.23% |
| 2020 FY | 141.08 Million EUR | 77.2% |
| 2020 Q1 | 72.57 Million EUR | -8.85% |
| 2020 Q2 | 83.46 Million EUR | 15.0% |
| 2019 Q3 | 74.03 Million EUR | -19.6% |
| 2019 FY | 79.61 Million EUR | 104.58% |
| 2019 Q4 | 79.61 Million EUR | 7.54% |
| 2019 Q2 | 92.08 Million EUR | 103.37% |
| 2019 Q1 | 45.27 Million EUR | 16.34% |
| 2018 FY | 38.91 Million EUR | 63.74% |
| 2018 Q4 | 38.91 Million EUR | 25.42% |
| 2018 Q2 | 36.63 Million EUR | 110.41% |
| 2018 Q1 | 17.41 Million EUR | -26.74% |
| 2018 Q3 | 31.02 Million EUR | -15.31% |
| 2017 Q1 | 17.93 Million EUR | 33.28% |
| 2017 Q4 | 23.76 Million EUR | 19.5% |
| 2017 Q2 | 15.93 Million EUR | -11.16% |
| 2017 FY | 23.76 Million EUR | 76.61% |
| 2017 Q3 | 19.89 Million EUR | 24.82% |
| 2016 Q2 | 11.82 Million EUR | 9.83% |
| 2016 Q3 | 12.35 Million EUR | 4.45% |
| 2016 Q1 | 10.76 Million EUR | -5.92% |
| 2016 FY | 13.45 Million EUR | 17.59% |
| 2016 Q4 | 13.45 Million EUR | 8.96% |
| 2015 Q1 | 12.09 Million EUR | -5.96% |
| 2015 Q4 | 11.44 Million EUR | 19.88% |
| 2015 Q3 | 9.54 Million EUR | -22.9% |
| 2015 Q2 | 12.38 Million EUR | 2.38% |
| 2015 FY | 11.44 Million EUR | -11.01% |
| 2014 Q2 | 15.98 Million EUR | 0.0% |
| 2014 Q3 | 13.22 Million EUR | -17.23% |
| 2014 Q4 | 12.86 Million EUR | -2.78% |
| 2014 FY | 12.86 Million EUR | -36.95% |
| 2014 Q1 | - EUR | -100.0% |
| 2013 Q1 | - EUR | 0.0% |
| 2013 Q4 | 20.39 Million EUR | 0.0% |
| 2013 FY | 20.39 Million EUR | -14.47% |
| 2012 FY | 23.84 Million EUR | 5.6% |
| 2011 FY | 22.58 Million EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -5872.354% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -8799.432% |
| Vaxxinity, Inc. | 30.94 Million USD | -3038.844% |
| IO Biotech, Inc. | 17.55 Million USD | -5432.49% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -2395.142% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -1800.64% |
| MEI Pharma, Inc. | 8.35 Million USD | -11525.183% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -413.483% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | -99.606% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -6654.879% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -1555.109% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -2468.719% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -72624.632% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -175.264% |
| Agenus Inc. | 462.29 Million USD | -110.1% |
| AlloVir, Inc. | 45.01 Million USD | -2057.69% |
| CRISPR Therapeutics AG | 346.76 Million USD | -180.096% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -179.442% |
| NextCure, Inc. | 14.99 Million USD | -6376.522% |
| Opthea Limited | 264.6 Million USD | -267.075% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -1978.102% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -565.86% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -14600.212% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -3467.225% |
| Senti Biosciences, Inc. | 52.57 Million USD | -1747.566% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -256.713% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -30010.116% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 76.021% |
| BioLineRx Ltd. | 50.7 Million USD | -1815.672% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -11550.282% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -3430.53% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -10146.693% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -2593.671% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -1470.793% |
| AbCellera Biologics Inc. | 335.77 Million USD | -189.265% |
| ADMA Biologics, Inc. | 193.97 Million USD | -400.724% |
| Aptorum Group Limited | 5.25 Million USD | -18376.934% |
| AnaptysBio, Inc. | 364.28 Million USD | -166.627% |
| Ardelyx, Inc. | 130.76 Million USD | -642.782% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | -103.032% |
| Bicycle Therapeutics plc | 224.41 Million USD | -332.813% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -645.937% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -645.21% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -1845.291% |
| Chimerix, Inc. | 19.74 Million USD | -4819.139% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -2661.125% |
| Dyadic International, Inc. | 2.34 Million USD | -41396.319% |
| Elevation Oncology, Inc. | 34.28 Million USD | -2733.219% |
| ESSA Pharma Inc. | 3.49 Million USD | -27690.108% |
| Fortress Biotech, Inc. | 165.93 Million USD | -485.326% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -604.851% |
| GlycoMimetics, Inc. | 6.9 Million USD | -13972.35% |
| Fortress Biotech, Inc. | 165.93 Million USD | -485.326% |
| ChromaDex Corporation | 26.5 Million USD | -3564.116% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -137674.102% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -1938.371% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -1238.465% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -3341.097% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -267.368% |
| Incyte Corporation | 1.59 Billion USD | 39.0% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -1647.062% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -23400.702% |
| Jaguar Health, Inc. | 45.86 Million USD | -2017.656% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 87.314% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -39625.317% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -643.1% |
| ContextLogic Inc. | 206 Million USD | -371.497% |
| Lantern Pharma Inc. | 2.73 Million USD | -35352.436% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -312.936% |
| MiMedx Group, Inc. | 96.33 Million USD | -908.288% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -530.119% |
| Structure Therapeutics Inc. | 29.05 Million USD | -3243.375% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -1258.819% |
| Onconetix, Inc. | 23.18 Million USD | -4090.021% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -14446.713% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -7924.024% |
| PDS Biotechnology Corporation | 33.25 Million USD | -2820.353% |
| Precigen, Inc. | 41.64 Million USD | -2232.35% |
| Pharming Group N.V. | 244.07 Million USD | -297.948% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -8046.989% |
| PureTech Health plc | 125.58 Million USD | -673.42% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -3593.938% |
| Royalty Pharma plc | 6.29 Billion USD | 84.577% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -14600.212% |
| Seer, Inc. | 39.36 Million USD | -2367.38% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -1078.271% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -14521.165% |
| Acelyrin, Inc. | 86.35 Million USD | -1024.783% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -74657.801% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -1922.581% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -27423.806% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -541.061% |
| TG Therapeutics, Inc. | 169.08 Million USD | -474.435% |
| Alkermes plc | 933.53 Million USD | -4.043% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -328.195% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -67163.435% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -3474.971% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -23929.787% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -10269.211% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -327.041% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -660.057% |
| Geron Corporation | 146.12 Million USD | -564.685% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -3247.524% |
| Summit Therapeutics Inc. | 125.25 Million USD | -675.433% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -1312.222% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -49556.646% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -27425.069% |
| Innoviva, Inc. | 568.55 Million USD | -70.835% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -9837.426% |
| Vaxcyte, Inc. | 167.44 Million USD | -480.048% |
| Molecular Templates, Inc. | 31.17 Million USD | -3015.986% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -10752.335% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | -96.414% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -2431.165% |
| Novavax, Inc. | 2.57 Billion USD | 62.24% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -3587.627% |
| Scopus BioPharma Inc. | 7.45 Million USD | -12929.614% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -1055.933% |
| Precision BioSciences, Inc. | 140.92 Million USD | -589.245% |
| GT Biopharma, Inc. | 6.63 Million USD | -14543.208% |
| ImmuCell Corporation | 18.81 Million USD | -5062.279% |
| Immix Biopharma, Inc. | 3.72 Million USD | -25997.276% |
| Mesoblast Limited | 188.79 Million USD | -414.457% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -1216.692% |
| Aptose Biosciences Inc. | 15.8 Million USD | -6043.984% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -8698.113% |
| Soligenix, Inc. | 7.27 Million USD | -13251.159% |
| Century Therapeutics, Inc. | 175.94 Million USD | -452.051% |
| Kura Oncology, Inc. | 51.66 Million USD | -1780.074% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -700.848% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -14585.596% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -284.518% |
| Autolus Therapeutics plc | 263.9 Million USD | -268.04% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -9166.209% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -993.037% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -1971.012% |
| GRI Bio, Inc. | 2.69 Million USD | -35913.496% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -119873.073% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -3024.004% |
| IGM Biosciences, Inc. | 220.17 Million USD | -341.138% |
| INmune Bio, Inc. | 18.86 Million USD | -5049.422% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -278.699% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -3545.713% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -35629.909% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -29509.916% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -1561.593% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -910.081% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -266.889% |
| Coherus BioSciences, Inc. | 823.02 Million USD | -18.013% |
| Verastem, Inc. | 71.18 Million USD | -1264.45% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -1875.118% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -2417.715% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -1884.967% |
| Histogen Inc. | 5.69 Million USD | -16949.043% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -22047.093% |
| Surrozen, Inc. | 8.14 Million USD | -11824.911% |
| Organovo Holdings, Inc. | 2.74 Million USD | -35245.124% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -309366.064% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -1627.344% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -5782.292% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -117364.429% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -666.45% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -8882.068% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -543.708% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -37151.84% |
| Apollomics, Inc. | 14.15 Million USD | -6762.743% |
| Amarin Corporation plc | 279.58 Million USD | -247.4% |
| Turnstone Biologics Corp. | 14.14 Million USD | -6765.168% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -437.25% |
| Synaptogenix, Inc. | 5.52 Million USD | -17465.593% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -14510.168% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -470.981% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -11250.498% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -55168.457% |
| Exelixis, Inc. | 678.44 Million USD | -43.163% |
| Better Therapeutics, Inc. | 23.84 Million USD | -3973.836% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -492.08% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | -63.458% |
| NLS Pharmaceutics AG | 10.68 Million USD | -8994.246% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -59722.273% |
| Gritstone bio, Inc. | 125.91 Million USD | -671.356% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -6518.179% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -18987.349% |
| Avid Bioservices, Inc. | 275.66 Million USD | -252.338% |
| Insmed Incorporated | 1.66 Billion USD | 41.551% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -12523.875% |
| MediWound Ltd. | 27.18 Million USD | -3472.605% |
| OmniAb, Inc. | 87.4 Million USD | -1011.309% |
| Alector, Inc. | 487.66 Million USD | -99.169% |
| Seres Therapeutics, Inc. | 403.45 Million USD | -140.741% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -5171.555% |
| Zai Lab Limited | 240.17 Million USD | -304.403% |
| Revance Therapeutics, Inc. | 630.05 Million USD | -54.158% |
| Aura Biosciences, Inc. | 29.22 Million USD | -3223.242% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -921.576% |
| Immunic, Inc. | 25.36 Million USD | -3728.776% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -1302.86% |
| Veracyte, Inc. | 93.71 Million USD | -936.379% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -37019.044% |
| FibroGen, Inc. | 585.72 Million USD | -65.825% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -5487.551% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -148624.498% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -17074.277% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -11747.817% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -1055.988% |
| Galecto, Inc. | 5.89 Million USD | -16373.609% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -11624.819% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 62.905% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -3269.94% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -7595.777% |
| XBiotech Inc. | 8.39 Million USD | -11467.036% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -6518.179% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -1726.408% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -167.493% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -3512.87% |
| Theravance Biopharma, Inc. | 169 Million USD | -474.711% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 20.098% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | -94.091% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | 0.124% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -16004.573% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | -30.333% |
| NexImmune, Inc. | 5.08 Million USD | -19003.849% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -261423.88% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -31488.033% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 86.334% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -18745.137% |
| Ainos, Inc. | 7.39 Million USD | -13035.714% |
| Pluri Inc. | 34.11 Million USD | -2747.338% |
| Prothena Corporation plc | 135.01 Million USD | -619.379% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -299.536% |
| Celularity Inc. | 102.92 Million USD | -843.645% |
| Rallybio Corporation | 9.43 Million USD | -10193.387% |
| Cue Biopharma, Inc. | 24.44 Million USD | -3873.344% |
| MeiraGTx Holdings plc | 319.99 Million USD | -203.535% |
| Omeros Corporation | 403.25 Million USD | -140.863% |
| Humacyte, Inc. | 114.67 Million USD | -746.974% |
| Immunocore Holdings plc | 228.15 Million USD | -325.707% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -19823.774% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -1165.682% |
| Blueprint Medicines Corporation | 918.64 Million USD | -5.731% |
| CalciMedica, Inc. | 4.02 Million USD | -24013.307% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -5465.46% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -1031.808% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -249.643% |
| Pulmatrix, Inc. | 15.96 Million USD | -5984.596% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -6057.89% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -3847.346% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -287.262% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -1812.503% |
| Cytokinetics, Incorporated | 1.21 Billion USD | 19.771% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -2955.986% |
| Nutriband Inc. | 1.07 Million USD | -89923.811% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -9034.619% |
| Vor Biopharma Inc. | 59.1 Million USD | -1543.347% |
| Roivant Sciences Ltd. | 773.95 Million USD | -25.497% |
| Evogene Ltd. | 17.99 Million USD | -5299.022% |
| ProKidney Corp. | 29.21 Million USD | -3224.493% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -1249.399% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 48.58% |
| CorMedix Inc. | 11.91 Million USD | -8050.046% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -549.867% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -998.228% |
| Atai Life Sciences N.V. | 49.16 Million USD | -1875.68% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -3017.856% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -5307.438% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -679.297% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -17078.705% |
| MediciNova, Inc. | 3.89 Million USD | -24858.776% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -5213.66% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -64469.707% |
| GeoVax Labs, Inc. | 3.51 Million USD | -27494.228% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | -144.496% |
| Biomea Fusion, Inc. | 30.69 Million USD | -3064.822% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 64.314% |
| Mereo BioPharma Group plc | 15.96 Million USD | -5984.977% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -3012.99% |
| Absci Corporation | 58.3 Million USD | -1565.896% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -4999.139% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -2929.393% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -1216.281% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -1010.255% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -2776.174% |
| Allakos Inc. | 74.79 Million USD | -1198.63% |
| Imunon, Inc. | 8.53 Million USD | -11286.112% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -4216.626% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -745.978% |
| BioAtla, Inc. | 48.98 Million USD | -1882.779% |
| NLS Pharmaceutics AG | 10.68 Million USD | -8994.246% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -34850.846% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -643.686% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -6732.81% |
| XOMA Corporation | 145.58 Million USD | -567.182% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -2785.145% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -1312.592% |
| aTyr Pharma, Inc. | 31.59 Million USD | -2973.975% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -1471.072% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -2060.089% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -1906.702% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -33742.648% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -11805.882% |
| Akari Therapeutics, Plc | 4.58 Million USD | -21088.569% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -5377.228% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 41.115% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -240371.593% |
| UroGen Pharma Ltd. | 243.52 Million USD | -298.847% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -202.499% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -35071.595% |
| Orgenesis Inc. | 35.53 Million USD | -2633.316% |
| Entera Bio Ltd. | 1.37 Million USD | -70333.938% |
| GH Research PLC | 6.7 Million USD | -14394.613% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -14183.588% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -5059.269% |
| Xencor, Inc. | 283.55 Million USD | -242.533% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -32431.471% |
| Replimune Group, Inc. | 113.21 Million USD | -757.919% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -25751.788% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -838.167% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -240371.593% |
| Portage Biotech Inc. | 4.45 Million USD | -21726.607% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -64469.707% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -4113.813% |
| OncoCyte Corporation | 49.29 Million USD | -1870.23% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -23379.086% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -121693.541% |
| Purple Biotech Ltd. | 10 Million USD | -9607.986% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -16686.796% |
| scPharmaceuticals Inc. | 57.26 Million USD | -1596.24% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -7740.51% |
| HilleVax, Inc. | 78.9 Million USD | -1130.891% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -19133.347% |
| Tharimmune, Inc. | 1.81 Million USD | -53412.914% |
| Genprex, Inc. | 3.25 Million USD | -29747.017% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -3481.563% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -18450.115% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -471397.087% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -270793.716% |
| OKYO Pharma Limited | 7.42 Million USD | -12988.589% |
| Savara Inc. | 37.19 Million USD | -2511.54% |
| Curis, Inc. | 57.61 Million USD | -1585.906% |
| Daré Bioscience, Inc. | 26.32 Million USD | -3588.908% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -2377.778% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -4565.373% |
| BeiGene, Ltd. | 2.23 Billion USD | 56.518% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -4462.203% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -270.158% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -4465.592% |
| Erasca, Inc. | 78.61 Million USD | -1135.557% |
| bluebird bio, Inc. | 424.62 Million USD | -128.74% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -148130.604% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 48.611% |
| DBV Technologies S.A. | 42.8 Million USD | -2169.355% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -148130.604% |
| Moderna, Inc. | 4.57 Billion USD | 78.756% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -13785.404% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -58552.415% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -5590.006% |
| Travere Therapeutics, Inc. | 588.1 Million USD | -65.155% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -680.116% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -3440.052% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -2564.264% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -1645.815% |
| MacroGenics, Inc. | 154.2 Million USD | -529.857% |
| RenovoRx, Inc. | 4.46 Million USD | -21648.41% |
| Adicet Bio, Inc. | 37.12 Million USD | -2516.606% |
| Prime Medicine, Inc. | 60.78 Million USD | -1498.032% |
| Aditxt, Inc. | 28.53 Million USD | -3304.245% |
| Adagene Inc. | 45.16 Million USD | -2050.317% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -537408.924% |
| Quantum-Si incorporated | 26.63 Million USD | -3547.193% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | -39.239% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -31824.529% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -744.881% |
| SciSparc Ltd. | 1.59 Million USD | -60795.549% |
| Vericel Corporation | 127.7 Million USD | -660.568% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -17353.774% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -1037.893% |
| Generation Bio Co. | 171.63 Million USD | -465.917% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -8309.385% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -2221.924% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -284.366% |
| Invivyd, Inc. | 51.71 Million USD | -1778.22% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -956.007% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -14830.769% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -1186.537% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -95030.656% |
| 2seventy bio, Inc. | 310.12 Million USD | -213.19% |
| Clene Inc. | 38.95 Million USD | -2393.605% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -2588.091% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -277.967% |
| GeoVax Labs, Inc. | 3.51 Million USD | -27494.228% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -410.495% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -7874.638% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -389.751% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -7864.739% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -1918.84% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -1738.126% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -162.613% |
| Evaxion Biotech A/S | 17.61 Million USD | -5413.183% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -503.548% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -534.055% |
| Trevena, Inc. | 48.26 Million USD | -1912.523% |
| Surrozen, Inc. | 8.14 Million USD | -11824.911% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -4397.726% |
| Cingulate Inc. | 10.36 Million USD | -9274.545% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -35219.418% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -2504.537% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -26981.516% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -7286.19% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -206.205% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -3808.745% |
| Clearmind Medicine Inc. | 3.61 Million USD | -26805.314% |
| Kronos Bio, Inc. | 54.2 Million USD | -1692.004% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -1964.673% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -4167.555% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -4739.241% |
| Statera Biopharma, Inc. | 22.67 Million USD | -4183.227% |
| ImmunityBio, Inc. | 1.09 Billion USD | 10.923% |
| Korro Bio, Inc. | 51.75 Million USD | -1776.805% |
| Kineta, Inc. | 7.22 Million USD | -13348.962% |
| BioVie Inc. | 9.7 Million USD | -9911.039% |
| Codexis, Inc. | 49.94 Million USD | -1844.668% |
| Celularity Inc. | 102.92 Million USD | -843.645% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -909.158% |
| Celcuity Inc. | 51.45 Million USD | -1787.818% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -281273.373% |
| Cibus, Inc. | 206.11 Million USD | -371.229% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -2186.719% |
| IN8bio, Inc. | 8.77 Million USD | -10972.549% |
| Kodiak Sciences Inc. | 213.59 Million USD | -354.74% |
| Annexon, Inc. | 47.11 Million USD | -1961.386% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -984.737% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -907.849% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -6995.361% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 62.692% |
| Eyenovia, Inc. | 19.78 Million USD | -4810.365% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -448.482% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -12545.281% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -3930.391% |
| Arcellx, Inc. | 339.75 Million USD | -185.88% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -8063.422% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -295.571% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -10056.687% |
| Moolec Science SA | 13.94 Million USD | -6864.928% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -2150.844% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -1822.117% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -2341.885% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -329813.113% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -39378.564% |
| Humacyte, Inc. | 114.67 Million USD | -746.974% |
| 89bio, Inc. | 59.96 Million USD | -1519.806% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -3570.347% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -81111.037% |
| Genelux Corporation | 8.42 Million USD | -11435.439% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -14066.919% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -612.508% |
| Notable Labs, Ltd. | 4.42 Million USD | -21840.005% |
| Liquidia Corporation | 73.13 Million USD | -1228.016% |
| Mustang Bio, Inc. | 17.61 Million USD | -5412.708% |
| Immunovant, Inc. | 48.95 Million USD | -1884.034% |
| Quantum-Si incorporated | 26.63 Million USD | -3547.193% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -2430.506% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -31201.45% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -1215.016% |
| Acasti Pharma Inc. | 11.55 Million USD | -8304.292% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -4196.247% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -35629.909% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -2533.848% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -71169.01% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -15833.136% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -3810.948% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -4089.458% |
| PepGen Inc. | 34.63 Million USD | -2704.666% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -7898.057% |
| United Therapeutics Corporation | 1.18 Billion USD | 17.841% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -13807.274% |
| Solid Biosciences Inc. | 38.45 Million USD | -2425.571% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -11250.498% |
| Immuneering Corporation | 12 Million USD | -7988.402% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -309366.064% |
| Silo Pharma, Inc. | 1.56 Million USD | -61794.002% |
| Belite Bio, Inc | 4.21 Million USD | -22965.4% |
| XOMA Corporation | 145.58 Million USD | -567.182% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -39903.46% |
| Bionomics Limited | 10.15 Million USD | -9461.085% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -4419.492% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -4139.008% |
| uniQure N.V. | 624.01 Million USD | -55.65% |
| Cassava Sciences, Inc. | 14.19 Million USD | -6742.437% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -537408.924% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -470.726% |
| Forte Biosciences, Inc. | 3.66 Million USD | -26394.381% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -372634.983% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -14295.791% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -12545.281% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -5487.551% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -9090.802% |
| Altimmune, Inc. | 16.54 Million USD | -5771.979% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | -57.24% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -4139.008% |
| Compugen Ltd. | 55.77 Million USD | -1641.433% |
| Peak Bio, Inc. | 20.75 Million USD | -4580.128% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -779.284% |
| Benitec Biopharma Inc. | 4.96 Million USD | -19474.446% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -515.348% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -1192.048% |
| Zura Bio Limited | 21.29 Million USD | -4461.732% |
| PolyPid Ltd. | 17.46 Million USD | -5460.362% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -764.139% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -1192.048% |
| Instil Bio, Inc. | 99.8 Million USD | -873.221% |
| argenx SE | 444.95 Million USD | -118.29% |
| Immunome, Inc. | 28.65 Million USD | -3289.225% |
| Verona Pharma plc | 58.84 Million USD | -1550.693% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -6611.007% |
| Shattuck Labs, Inc. | 14.85 Million USD | -6436.671% |
| CervoMed Inc. | 2.59 Million USD | -37318.285% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -19827.862% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -7526.288% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -9119.592% |
| Moolec Science SA | 13.94 Million USD | -6864.928% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -41345.801% |
| Design Therapeutics, Inc. | 11.95 Million USD | -8023.821% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -7557.553% |
| NeurAxis, Inc. | 1.91 Million USD | -50679.746% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -2395.078% |
| Lumos Pharma, Inc. | 13.33 Million USD | -7184.812% |
| Achilles Therapeutics plc | 19.08 Million USD | -4988.72% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -6611.007% |
| 180 Life Sciences Corp. | 5.38 Million USD | -17929.447% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -4017.706% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -4167.555% |
| Nutriband Inc. | 1.07 Million USD | -89923.811% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -3074.338% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -6593.433% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | -142.05% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -2891.051% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -7343.305% |
| Palisade Bio, Inc. | 2.73 Million USD | -35361.263% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -18390.082% |
| Beam Therapeutics Inc. | 478.38 Million USD | -103.034% |
| Neurogene Inc. | 36.54 Million USD | -2557.484% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | -144.071% |
| AEON Biopharma, Inc. | 159.88 Million USD | -507.474% |
| Sesen Bio, Inc. | 30.98 Million USD | -3034.792% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -3641.32% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -12676.327% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -396.216% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -405.727% |
| Athira Pharma, Inc. | 30.05 Million USD | -3131.474% |
| Vaccinex, Inc. | 5.94 Million USD | -16246.079% |
| HCW Biologics Inc. | 15.05 Million USD | -6352.881% |
| XOMA Corporation | 145.58 Million USD | -567.182% |
| Nektar Therapeutics | 267.04 Million USD | -263.714% |
| Arvinas, Inc. | 644.6 Million USD | -50.68% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -5377.228% |
| Merus N.V. | 102.15 Million USD | -850.832% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -563.672% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -921.114% |
| Rezolute, Inc. | 11.73 Million USD | -8177.518% |
| Clene Inc. | 38.95 Million USD | -2393.605% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -34011.499% |
| BeyondSpring Inc. | 48.26 Million USD | -1912.231% |
| Synlogic, Inc. | 32.89 Million USD | -2852.68% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -6546.712% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -59342.105% |
| Peak Bio, Inc. | 20.75 Million USD | -4580.128% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -1430.569% |
| Krystal Biotech, Inc. | 39.71 Million USD | -2345.697% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -157.879% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -875.488% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -224357.047% |
| MannKind Corporation | 721.36 Million USD | -34.645% |
| Ikena Oncology, Inc. | 22.33 Million USD | -4248.708% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -46462.033% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -846.763% |
| Gossamer Bio, Inc. | 249.14 Million USD | -289.844% |
| CohBar, Inc. | 1.03 Million USD | -93867.521% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -8986.762% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -4999.139% |
| Legend Biotech Corporation | 589.93 Million USD | -64.643% |
| Mural Oncology plc | 37.92 Million USD | -2460.863% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -632.293% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -42215.621% |
| Disc Medicine, Inc. | 22.87 Million USD | -4146.05% |
| Champions Oncology, Inc. | 28.03 Million USD | -3364.541% |
| REGENXBIO Inc. | 262.22 Million USD | -270.397% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -28812.838% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -7649.194% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -7131.321% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -4480.448% |
| Vaxart, Inc. | 34.02 Million USD | -2754.619% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -4663.703% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -3304.206% |
| Cellectis S.A. | 249.57 Million USD | -289.175% |
| Longeveron Inc. | 5.33 Million USD | -18099.063% |
| Repare Therapeutics Inc. | 41.81 Million USD | -2222.59% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 59.618% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -1508.939% |
| Revolution Medicines, Inc. | 262.39 Million USD | -270.158% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -45997.959% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -11159.958% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -8130.523% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -6816.499% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -45054.998% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 81.139% |
| Denali Therapeutics Inc. | 122.96 Million USD | -689.899% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -17353.774% |
| Veru Inc. | 32.81 Million USD | -2860.085% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -14040.108% |
| Cingulate Inc. | 10.36 Million USD | -9274.545% |
| Passage Bio, Inc. | 39.26 Million USD | -2373.853% |
| Context Therapeutics Inc. | 4.19 Million USD | -23071.518% |
| Exicure, Inc. | 8.54 Million USD | -11261.376% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -3191.595% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -9162.674% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -4306.715% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -495.931% |
| Nuvalent, Inc. | 31.82 Million USD | -2952.145% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -15167.855% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -1441.182% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -5296.022% |
| OmniAb, Inc. | 87.4 Million USD | -1011.309% |
| Anew Medical, Inc. | 8.24 Million USD | -11684.854% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -2436.712% |
| Lipocine Inc. | 2.63 Million USD | -36808.09% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -3597.031% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -2315.408% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -3545.713% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -1027.381% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -17883.41% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -1073.8% |
| Ocugen, Inc. | 23.98 Million USD | -3949.885% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -1992.969% |
| Q32 Bio Inc. | 233.12 Million USD | -316.631% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -10613.479% |
| Alumis Inc. Common Stock | 53.5 Million USD | -1715.416% |
| Equillium, Inc. | 27.95 Million USD | -3374.207% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -370.146% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -17162.162% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -15737.096% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -517.37% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -1298.879% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -9637.963% |
| Dominari Holdings Inc. | 4.63 Million USD | -20855.426% |
| Edesa Biotech, Inc. | 1.84 Million USD | -52640.252% |
| vTv Therapeutics Inc. | 29.56 Million USD | -3185.027% |
| Bio-Techne Corporation | 744.34 Million USD | -30.489% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -670.255% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -181.976% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -2293.799% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -3254.229% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -951.628% |
| Nkarta, Inc. | 105.6 Million USD | -819.777% |
| BioCardia, Inc. | 4.59 Million USD | -21060.871% |
| Iterum Therapeutics plc | 32.66 Million USD | -2873.743% |